ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print May 21, 2009, 10.1183/09031936.00102308
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/6/1399    most recent
09031936.00102308v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Aceto, N.
Right arrow Articles by Gaudino, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aceto, N.
Right arrow Articles by Gaudino, G.
Eur Respir J 2009; 34:1399-1407
Copyright ©ERS Journals Ltd 2009

Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma

N. Aceto1,2, P. Bertino1, D. Barbone1,3, G. Tassi4, L. Manzo5, C. Porta6, L. Mutti7,8 and G. Gaudino1,8

1 DISCAFF Dept and DFB Center, University of Piemonte Orientale "A. Avogadro", Novara, 4 Chest Medicine Unit, Brescia Hospital, Brescia, 5 Dept of Toxicology, University of Pavia, 6 Medical Oncology, IRCCS San Matteo University Hospital, Pavia, 7 Local Health Unit 11, Piemonte, Borgosesia, Italy. 2 Friedrich Mietscher Institute, Basel, Switzerland. 3 Lung Biology Center, SFGH, UCSF, San Francisco, CA, USA. 8 L. Mutti and G. Gaudino contributed equally to this work.

CORRESPONDENCE: G. Gaudino, Dept of Chemical, Food, Pharmaceutical and Pharmacological Sciences and Drug and Food Biotechnology Center, University of Piemonte Orientale "A. Avogadro", Via Bovio 6, 28100 Novara, Italy. E-mail: giovanni.gaudino{at}unipmn.it

Keywords: Akt, apoptosis, malignant mesothelioma, oxidative stress, taurolidine

Received: July 5, 2008
Accepted May 6, 2009

Malignant mesothelioma is an asbestos-related, aggressive tumour, resistant to most anticancer therapies. Akt is a key mediator of mesothelioma cell survival and chemoresistance. This study aimed to clarify the mechanism by which taurolidine (TN), a known synthetic compound with antimicrobial and antineoplastic properties, leads to mesothelioma cell death.

Apoptosis was studied by annexin V binding, cell cycle analysis, caspase-8 activation, poly(ADP-ribose) polymerase (PARP) cleavage and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labelling (TUNEL). Oxidative stress was measured by nitrite production and DNA oxidative damage. Protein expression and phosphorylation were evaluated by immunoprecipitation and immunoblotting.

TN induces cell death of mesothelioma cells, but not of non-neoplastic human mesothelial cells. After TN treatment of mesothelioma cells, Akt but not extracellular signal-regulated kinase (Erk) 1/2 activity is inhibited a in time- and dose-dependent manner. Protein phosphatase (PP)1{alpha} and PP2A are activated several hours after drug addition. Apoptosis induced by TN is driven by oxidative stress and cell exposure to sulfydryl donors, such as glutathione monoethylester and L-N-acetylcysteine, significantly reduced pro-apoptotic effects and Akt inhibition. Conversely, expression of constitutively activated Akt did not affect cytoxicity elicited by TN, which retained its ability to inhibit the kinase.

TN induces mesothelioma cell death via oxidative stress, accompanied by inhibition of Akt signalling. This provides a promising molecular rationale for TN as local treatment of malignant mesothelioma.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the European Respiratory Society.